Skip to main content
. 2018 Dec 14;24(8):e720–e729. doi: 10.1634/theoncologist.2018-0331

Figure 3.

image

Progression‐free survival. Survival of all patients (n = 47) (A) and according to ConC (n = 9) or SeqC (n = 38) treatment with direct‐acting antivirals with respect to first‐line immunochemotherapy (B).

Abbreviations: ConC, concurrent; SeqC, sequential.